Unfortunately, even with the use of US contrast agents, there is considerable overlap in the appearance of metastases and hepatocellular carcinoma (HCC). [21] On a case-by-case basis, clinical and ...

Hypoxia enhances proliferation, angiogenesis, metastasis, chemoresistance, and radioresistance of HCC; suppresses differentiation and apoptosis of HCC; and consequently leads to tumor malignancy.

This is called secondary liver cancer or liver metastases. Hepatocellular carcinoma is also called hepatoma or HCC. It's the most common type of primary liver cancer. Because of this, the information ...

Panelists discuss how emerging evidence suggests that combining transarterial chemoembolization (TACE) with systemic therapy ...

Bristol Myers BMY announced that the European Commission (EC) has approved the blockbuster immuno-oncology drug Opdivo (nivolumab) plus Yervoy (ipilimumab) for the first-line treatment of adult ...

Granted Both Orphan Drug & Fast Track designations for Amezalpat (TPST-1120) for the treatment of patients with Hepatocellular Carcinoma (HCC)• Announced Agreement with Roche to Support Advancement of ...

Shanghai Junshi Biosciences Co., Ltd (Junshi Biosciences, HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization ...